Abstract

ObjectiveThe purpose was to validate the prognostic value of an early optimal morphological response on CT in patients treated with bevacizumab-containing chemotherapy for unresectable colorectal cancer liver metastases (CLM). It...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Early tumor shrinkage (ETS) and deepness of response (DpR) in patients with metastatic esophageal cancer receiving a first-line treatment with DCF: Exploratory analysis of the JCOG0807.
Takashi Ura ... Yuko Kitagawa
Journal of Clinical Oncology | VOL. 33
Takashi Ura, et. al.Takashi Ura ... Yuko Kitagawa
20 Jan 2015
Comparison of computed tomography imaging analyses for evaluation after chemotherapy in patients with colorectal cancer: a retrospective pooled analysis of six phase II clinical trials.
Kosuke Hirose ... Takayuki Shimose
International Journal of Clinical Oncology | VOL. 24
Kosuke Hirose, et. al.Kosuke Hirose ... Takayuki Shimose
22 Jul 2019
Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases: A post hoc analysis of the WJOG4407G phase III study.
Ayumu Hosokawa ... Hitoshi Kusaba
Medicine | VOL. 99
Ayumu Hosokawa, et. al.Ayumu Hosokawa ... Hitoshi Kusaba
04 Sep 2020
Early tumor shrinkage (ETS) and deepness of response (DoR) to predict progression-free, postprogression, and overall survival: Results from the phase III TRIBE trial.
Chiara Cremolini ...
Journal of Clinical Oncology | VOL. 32
Chiara Cremolini, et. al.Chiara Cremolini ...
20 Jan 2014
View more papers

More From: Gut

Paper Title
Journal
Date
Author
GI highlights from the literature
Philip J Smith
Gut | VOL. 73
Philip J SmithPhilip J Smith
11 Jul 2024
Mast cells and histamine in cholangiocarcinoma: exploring overlooked avenues for enhanced patient management
Jonathan Pol ... Luca Fabris
Gut | VOL. 73
Jonathan Pol, et. al.Jonathan Pol ... Luca Fabris
11 Jul 2024
FGF-21 analogues for treatment of non-alcoholic steatohepatitis and fibrosis: a meta-analysis with fragility index of phase 2 randomised placebo-controlled trials
Alessandro Mantovani ... Giovanni Targher
Gut | VOL. 73
Alessandro Mantovani, et. al.Alessandro Mantovani ... Giovanni Targher
11 Jul 2024
Hypoxia-inducible factor-1α mediates reflux-induced epithelial-mesenchymal plasticity in Barrett’s oesophagus patients
Qiuyang Zhang ... Tianhong Su
Gut | VOL. 73
Qiuyang Zhang, et. al.Qiuyang Zhang ... Tianhong Su
11 Jul 2024
View more papers